Ulrik Svane Sørensen
Fondateur chez Acesion Pharma ApS
Profil
Ulrik Svane Sørensen is the founder and the Chief Operating Officer of Acesion Pharma ApS, a company he founded in 2011.
He has held this position since 2016.
Dr. Sørensen also has an education background, having studied at Copenhagen Business School where he obtained an undergraduate degree and a doctorate.
Postes actifs de Ulrik Svane Sørensen
| Sociétés | Poste | Début |
|---|---|---|
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Fondateur | 01/01/2011 |
Formation de Ulrik Svane Sørensen
| Copenhagen Business School | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
